Hospitals - Japan

Japan

In Japan, the revenue in the Hospitals market is forecasted to reach €237.20bn in 2024.
It is expected to exhibit a compound annual growth rate (CAGR 2024-2029) of 3.96%, resulting in a market volume of €288.10bn by 2029.
When compared globally, United States is projected to generate the highest revenue in the Hospitals market, amounting to €1,377.00bn in 2024.
In terms of per capita figures, the revenue generated per person in Japan is estimated to be €1.93k in 2024.
Japan's hospitals are leading the way in adopting advanced technology and robotics to enhance patient care and improve efficiency.

Key regions: United States, China, Germany, Japan, Europe

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The healthcare industry in Japan has been experiencing significant growth in recent years. This growth can be attributed to a number of factors, including an aging population, government initiatives to promote healthcare, and advancements in medical technology.

Customer preferences: Japanese consumers place a high value on healthcare and prioritize access to quality medical care. As the population ages, there is an increasing demand for healthcare services, particularly in the area of geriatric care. Patients are also seeking more personalized and convenient healthcare options, such as telemedicine and home healthcare services.

Trends in the market: One of the major trends in the Japanese healthcare industry is the shift towards preventative care and wellness. This has led to an increase in demand for health screening services and health management programs. Additionally, there is a growing trend towards digitalization and the use of technology in healthcare, such as electronic health records and remote patient monitoring.Another trend in the Japanese healthcare market is the consolidation of hospitals and healthcare providers. This trend is being driven by a number of factors, including rising healthcare costs and a shortage of medical professionals. As a result, many smaller hospitals and clinics are merging with larger healthcare systems in order to remain competitive.

Local special circumstances: One unique aspect of the Japanese healthcare industry is the role of traditional medicine. Traditional Japanese medicine, or Kampo, is a form of herbal medicine that has been used in Japan for centuries. While Western medicine is still the dominant form of healthcare in Japan, there is a growing interest in Kampo and other traditional healing practices.

Underlying macroeconomic factors: The Japanese government has been actively promoting the healthcare industry as part of its economic growth strategy. This has included initiatives to increase healthcare spending, promote medical tourism, and encourage the development of new medical technologies. Additionally, Japan's aging population has created a significant demand for healthcare services, which is expected to continue to drive growth in the industry for years to come.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.